With a market cap of $9.5 billion, Bio-Rad Laboratories, Inc. (BIO) operates in the healthcare and life sciences industry. The Hercules, California-based company develops and manufactures a wide range ...
Below is Validea's guru fundamental report for BIO RAD LABORATORIES INC (BIO). Of the 22 guru strategies we follow, BIO rates highest using our Book/Market Investor model based on the published ...
Bio-Rad Laboratories, Inc. (BIO) has experienced a rise in revenue growth in recent years thanks to strong sales of its Western Blotting, Digital PCR, and Process Media life science products. Several ...
Bio-Rad is a "picks and shovels" company in the life sciences industry, but lacks standout growth, margins, or returns, and that has been largely true for more than two decades. Recent trends in the ...
Bio-Rad’s business segments and geographic revenue distribution for Q4 2025 reveal the company’s diversified market presence: Segment Performance Analysis The Clinical Diagnostics segment emerged as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results